10/25/2021
https://congress.gov...
"To assist, Congress reauthorized GDUFA, which allowed FDA to collect generic drug user fees, which could then be used to hire additional inspectors."
"Today, the committee continues its longtime work of conducting oversight of the FDA's foreign drug inspection program."
"As has been mentioned today, this committee has been examining FDA's foreign drug inspection program for nearly two decades."
"But, in the FDA's Safety and Innovation Act, Congress required that the commercial importers register with the FDA..."